Quote:
Originally Posted by gaming_mouse
No, it was not a feat then or now
Quote:
Originally Posted by Neil S
Amazon's one click boils down to 'Hey, cookies exist. Let's use them in commerce.' It was an incredibly stupid patent to award.
Fine fine, I stand corrected. I just a faint memory of the internet really sucking back then.
The largest companies in said Industry earned about $100m / year, but the lions share only earned about $20m / year. Reality is that the industry as a whole is so hog-tied and backwards that no company is really making money and I would guess that over half of them -- including the large ones -- are operating in the red.
So, patents, trademarks, and all those other add-ons were really vanity costs. A company could say "Patented Item!" and it would take but a button click to find 20 more products that were indistinguishable from the patented product, and in fact, because of something silly like, you only have to screw the lid 3 times as opposed to 4 times, both of the products were patented (once again, most of them design patents). <- obvious exaggeration
The others were usually blatant rip-offs with no care or respect to the patented product. Why? Well, this is the big issue: no one can afford to protect their patents. I think this is a terrible thing, not because I am "for" patents, but because it is misleading to the customer. The only advantage is that it assumes that the product is licensed from the patent-holder, when clearly this isn't the truth.
About 2 months ago, I interviewed with a company that held the obvious TMs on their name and logo. I did some research on the company before going in, and there was no less than 3 other companies with the exact same name, and there was one other that stole their logos. Since I didn't know, I asked if they were also those companies, and they told me that they couldn't afford to fight off those people that stole all of their logos and names.
The supposed promise of patents and trademarks is that the company should be the sole profiteer of the product, and others can emulate and improve, but not copy, but when you combine the thick quagmire of patent law, the costs of protecting the patent, and the ability to call China to create a copy of another product, the entire idea no longer holds any value.
As for drugs, I think that the remarketing of life-affecting generics as if it is brand-new, especially direct-to-customer, is reprehensible.